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A B S T R A C T
The aim of this study was to evaluate the usefulness of visual evoked potential (VEP) testing in detecting retinal gan-
glion cell damage in patients with Diabetes Mellitus type I (DMI). VEP arise before diabetic retinopathy signs become
ophthalmoscopically detectable. VEP testing was performed in 45 patients divided into three groups; 15 children with re-
cently discovered DMI, 15 children with long-lasting DMI, and 15 healthy children as the control group. A statistically
significant difference in VEP P100 wave amplitudes (Z=4.02, p<0.001) and latencies (Z=–4.66, p<0.001) was found be-
tween children with established DMI and those with recently discovered DMI. Amplitude values decrease progressively
and latency values increase progressively in children with DMI as the years pass. Progressive increases in VEP latency
values are a direct sign of retinal ganglion cell damage, which takes place even before the first ophthalmoscopically de-
tectable signs of diabetic retinopathy arise. Therefore, VEP should be considered as a valid method for detecting pre-
diabetic retinopathy, which could contribute greatly to the prevention of diabetic retinopathy complications.
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Introduction
Type I Diabetes Mellitus (DMI) is a complex, polyge-
nic, self-destructive disease that has many possible etio-
logical factors. Chronic complications of DM1 are mostly
caused by blood vessel damage. The most frequent chro-
nic microvascular complications usually become clini-
cally evident in early adulthood, but they can also be seen
in the pediatric population. Fortunately, chronic micro-
vascular complications, such as cerebrovascular stroke,
cardiovascular diseases, and peripheral vascular disease
of the limbs, are very rare during puberty and adoles-
cence. Due to recent improvements in diagnostic proce-
dures, we have been able to detect even subclinical pa-
thological changes in children and adolescents.
Diabetic retinopathy is the leading cause of blindness
among patients between the ages of 20 and 65 years old
(the working population) in developed countries. Blind-
ness was absent from 86% of eyes among diabetic pa-
tients under 25 years old. According to the international
clinical classification of diabetic retinopathy, there are
three different stages: diabetic preretinopathy, nonproli-
ferative diabetic retinopathy, and proliferative diabetic
retinopathy.
Diabetic retinopathy is a manifestation of generalized
microangiopathy typically found in diabetics. Biochemi-
cal and cellular mechanisms that induce vascular and
extravascular lesions are complex and still partially un-
known. Chronic hyperglycemia is one certain cause of di-
abetic retinopathy. To date, there are four described
pathobiochemical mechanisms that underlie hypergly-
cemic blood vessel damage: aldol reductase activity, pro-
tein kinase C activation, high levels of glycosylated com-
pounds, and free oxygen radical production.
Ophthalmologic electrodiagnostic findings allow us to
localize the damaged part of the visual path. Diabetic
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retinopathy involves all retinal layers. Electroretino-
gram (ERG) and visual evoked potential (VEP) findings
reflect the grade of organic damage. In early-stage diabe-
tes, ERG reveal changes in »b« waves; in late-stage dia-
betes, there are some changes in »a« waves too. Multiple
previous studies showed that VEP findings may identify
pathology in both early- and late-stage diabetes. The sen-
sitivity of neurophysiological examinations permits the
detection of retinal dysfunction, even before clinical ma-
nifestations develop and while visual acuity is still nor-
mal. According to previously cited literature, damage of
retinal ganglion cells may occur even before vascular le-
sions become clinically visible. Our hypothesis was that
there is a direct correlation between ischemic ganglion
cell changes and VEP parameters. The aim of this study
was to determine the role of VEP testing in evaluation of
ganglion cell damage, which is a sign of diabetic prere-
tinopathy.
Materials and Methods
This study included 45 patients, who were divided
into 3 study groups of 15 patients each. The first group
consisted of children who were 9 to 12 years old with re-
cently diagnosed DMI. The second group consisted of pa-
tients who were 9 to 12 years old, who had been treated
for DMI for years. The last was the control group, which
consisted of healthy children who were 9 to 12 years old.
All patients were submitted to endocrinological and
ophthalmological examination, which included examina-
tion of visual acuity, direct ophthalmoscopy on dilated
pupils, VEP testing (Primus-Tomey) with a square-pat-
tern stimulus with space frequency of 73.20 min., time
frequency of 1 rps, contrast 99%, time of acquisition 300
ms. Each eye was tested separately. The fundus photo-
graph was obtained using the Zeiss FF 450 plus fundus
camera. Examinations were performed at the Eye Clinic
Outpatients Department and at the Pediatric Endocri-
nology Department of Split University Hospital, Croatia.
Good regulation of blood glucose levels was the inclu-
sion criteria for all patients. Informed consent was ob-
tained from one parent of each child. Statistical analysis
was performed with Statistica 6.0 software (StatSoft
Inc.). Differences between groups were analyzed with the
Kruskal-Wallis test, Mann-Whitney U-test and Wilcoxon
matched-pair test. Pearson’s correlation coefficient was
calculated to determine the correlation between vari-
ables.
Results
All examined patients had normal eye fundus find-
ings. Most important demographic and other character-
istics of the three examined groups are listed in Table 1.
No statistically significant difference was found be-
tween values of measured amplitudes and latencies in
the eyes of each of the three groups (Table 2); therefore,
further calculations were all calculated using mean val-
ues that considered both right and left eyes.
Statistical analysis showed that there was a signifi-
cant difference among the three groups in P100 wave
amplitude (Kruskal-Wallis test, H=22.69, p<0.001) (Fig-
ure 1). Further analysis showed that there was a very
significant difference between the amplitude values of
children with established DM1 and the control group
(Mann-Whitney U-test, Z=4.17, p<0.001). No difference
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TABLE 1
DEMOGRAPHIC DATA FOR THE THREE STUDY GROUPS
Study group
Children with recently





Number of patients 15 15 15
Gender (M/F) 9/6 7/8 10/5
Age median (range) 10 (9–13) 19 (18–21) 10 (9–13)
Median duration of diabetes in years (range) – 8 (7–10) –
TABLE 2
COMPARISON OF RIGHT- AND LEFT-EYE P100 WAVE AMPLITUDES AND LATENCIES AS MEASURED IN ALL THREE STUDY GROUPS
Right eye D (range) Left eye D (range) p-value*
Children with recently
discovered diabetes type 1
Amplitude 11.10 (9.8–12.1) 11.3 (9.7–12.2) 0.9171
Latency 105.9 (103.8–106.1) 105.9 (103.8–106.1) 1.0000
Children with established
diabetes type 1
Amplitude 9.8 (8.7–11.0) 9.6 (8.6–11.1) 0.9503
Latency 110.9 (109.8–111.7) 110.9 (109.8–111.7) 0.9336
Control group
Amplitude 11.3 (9.9–12.5) 11.4 (9.5–12.1) 0.9334
Latency 106.0 (103.9–106.1) 106.00 (103.9–106.1) 0.8642
*Mann-Whitney U-test
was found between recently discovered diabetic children
and the control group (Mann-Whitney U-test, Z=0.18,
p=0.85).
Statistical analysis of the P100 wave latencies showed
similar results. There was also a significant difference in
P100 wave latencies among the three examined groups
(Kruskal-Wallis test, H=29.74, p<0.001) (Figure 2). Fur-
ther analysis demonstrated again a significant difference
between the latencies of children with established DMI
and the control group (Mann-Whitney U-test, Z= –4.66,
p<0.001), but once more, no difference was found be-
tween children recently diagnosed with diabetes and the
control group (Mann-Whitney U-test, Z=0.39, p= 0.69).
We found a weak negative correlation between the num-
ber of years a patient has lived with diabetes and P100
wave amplitude (Pearson’s correlation coefficient, R=
–0.07). A somewhat more significant negative correlation
was found between the number of years a patient had
lived with diabetes and latency values (Pearson’s correla-
tion coefficient, R=–0.18).
P100 wave amplitudes in the group with recently dis-
covered DMI were significantly different from the ampli-
tudes in the group with established DMI (Mann-Whitney
U-test, Z=4.02, p<0.001). Lower amplitude values were
associated with increased age among diabetic patients
(Figure 3). Significant difference in P100 wave latencies
were also found between the same groups (Mann-Whit-
ney U-test, Z=–4.66, p<0.001), but latency values had
the tendency to increase with patient age (Figure 4).
Discussion
Electroretinogram (ERG) is an important electrodiag-
nostic procedure, which detects diffuse retinal changes.
ERG findings become pathological only if a large part of
the retina is damaged because ERG represent the re-
sponse of photoreceptors and Müller cells. Diabetic re-
tinopathy is ophthalmoscopically detectable because it
involves all retinal layers; therefore, ERG findings are
also pathological. The VEP represents cortical responses
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Fig. 1. P100 wave amplitude median and range in three study
groups (a=Control group, b=Children with recently discovered
diabetes mellitus type 1, c=Children with established Diabetes
Mellitus Type I).
Fig. 2. P100 wave latency medians and ranges in all three study
groups (a=Control group, b=Children with recently discovered
diabetes mellitus type 1, c=Children with established Diabetes
Mellitus Type I).
Fig. 3. Relation between age and P100 wave amplitude values in
patients with Diabetes Mellitus Type I.
Fig. 4. Relation between age and P100 wave latency values in pa-
tients with Diabetes Mellitus Type I.
upon visual stimulation and can also be used to evaluate
the visual path, which runs from retinal ganglion cells to
the visual cortex. Latency is retained as the most objec-
tive VEP parameter; amplitude is less reliable due to its
greater variability. Therefore, this paper focused more on
the correlation of latency values among the three groups
examined and the duration of diabetes. Vascular damage
in diabetic retinopathy is caused by products of non-en-
zymatic glycosylation; this evidence in combination with
retinal-specific neural transport theory suggests that the
etiology of diabetic retinopathy is not exclusively vascu-
lar; retinal ganglion cell damage theory suggests that
retinal function may be damaged even before vascular le-
sions arise. We found no statistically significant correla-
tion between diabetes duration and P100 wave latency
and amplitude, which indicates that ischemic neuronal
and other retinal structure damage generated by micro-
angiopathy is the major but not the only cause of neuro-
physiologic changes.
Extracellular glutamate accumulation in diabetes in-
dicates that retinal ganglion cell damage is caused by
glutamine excitotoxicity. Functional and anatomical
changes can arise even before vascular lesions. Color per-
ception dysfunction (decreased blue-yellow sensitivity)
and ERG changes (b-wave amplitude reduction) favor
this theory. Oxidative stress, apart from functional mi-
crocirculation abnormalities and physiologic consequen-
ces of glucose metabolism, has a significant role in the
pathogenesis of diabetic retinopathy. Oxidative stress
arises due to increased free radical and oxidant produc-
tion or diminished activity of antioxidative mechanisms.
No statistically significant difference in amplitude
and latency values was found between the group of chil-
dren recently discovered to be diabetic and the control
group, which indicates that there is no retinal ganglion
cell damage in patients with recently discovered DMI.
Differences in P100 wave amplitudes and latencies be-
tween the group of children with established DMI and
the control group indicate that VEP, as electrodiagnostic
examination method, detected retinal ganglion cell dam-
age in the second group. This ganglion cell damage can
be defined as a sign of preclinical diabetic retinopathy be-
cause no examined patients had ophthalmoscopically de-
tectable signs of diabetic retinopathy. These results favor
the neurogenic diabetic retinopathy development theory,
which states that P100 wave latency changes even before
the first clinical signs of eye fundus arise. We also noticed
a progressive decrease in P100 wave amplitude values
with increasing age among diabetic children, but ampli-
tude decreased with age in the general population (Fig-
ure 3). Latency values, in patients with DM1, tend to in-
crease with time, which is a direct sign of ganglion cell
damage (Figure 4).
In conclusion, this study showed that VEP is a valu-
able method to detect diabetic preretinopathy in children
suffering from DMI. It is known that therapy for diabetic
retinopathy is most effective if it is applied as soon as the
first signs of diabetic retinopathy arise. VEP is a non-in-
vasive examination method that facilitates detection of
early diabetic retinopathy changes, which is of great
value in blindness prevention. This study has also shown
that the first pathological neurophysiologic changes in
patients with DM1 arise between 8 and 10 years after the
onset of diabetes. Future studies should be focused on
evaluation of the time that elapses between the appear-
ance of the first detectable pathologic electrophysiologic
changes and the first ophthalmoscopically detectable ret-
inal changes in patients with DMI.
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PROMJENE VRIJEDNOSTI KRIVULJE VIDNO EVOCIRANIH POTENCIJALA U RANOM
OTKRIVANJU PREDIJABETI^NE FORME DIJABETI^NE RETINOPATIJE KOD BOLESNIKA
S JUVENILNIM DIJABETES MELITUSOM
S A @ E T A K
Cilj ove studije je bio ispitati zna~aj testiranja vidno evociranih potencijala u otkrivanju o{te}enja retinalnih ganglij-
skih stanica u bolesnika s diabetes mellitus tip 1, koja se javljaju prije pojave prvih oftalmoskopskih znakova dijabeti~ke
retinopatije. VEP testiranje se uradilo u 45 bolesnika podjeljenih u tri grupe; 15 djece s netom otkrivenim diabetes
mellitusom, 15 djece koji du`e boluju od dijabetesa, 15 zdrave djece kao kontrolne grupe. Statisti~ka zna~ajnost je
prona|ena u vrijednostima visine amplitude (Z=4,02, p<0,001) I latencije (Z=–4,66, p<0,001), izme|u djece koja du`e
vrijeme boluju od dijabetesa i grupe djece s netom otkrivenim dijabetesom. Tijekom trajanja bolesti vrijednosti ampli-
tude su progresivno padale za vrijednosti latencije su progresivno rasle u djece s dijabetes mellitusom. Vrijednosti
latencije krivulja vidno evociranih potencijala su rasle tijekom trajanja bolesti {to je direktan znak o{te}enja ganglijskih
stanica koje su se javile prije prvih oftalmoskopskih znakova dijabeti~ke retinopatije. Zbog toga je testiranje vidno
evociranim potencijalima zna~ajna metoda za otkrivanje prvih znakova retinopatije u djece s dijabetesom mellitusom
tip 1.
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